Mode
Text Size
Log in / Sign up

Natural polysaccharides enhance insulin sensitivity and protect pancreatic beta-cells in type 2 diabetes

Natural polysaccharides enhance insulin sensitivity and protect pancreatic beta-cells in type 2…
Photo by Mila / Unsplash
Key Takeaway
Consider natural polysaccharides as a theoretical framework for T2DM management.

This comprehensive review evaluates the potential role of natural polysaccharides in managing type 2 diabetes. The scope covers mechanistic pathways and theoretical benefits rather than clinical trial data. The authors describe how these compounds may enhance insulin sensitivity and glucose metabolism via PI3K/Akt and AMPK signaling pathways.

The review further details pancreatic beta-cell protection from apoptosis and promotion of insulin secretion. Additionally, the text outlines suppression of chronic inflammation through NF-kB and NLRP3 pathway inhibition. The authors also note attenuation of oxidative stress via Nrf2/HO-1 pathway activation.

Regarding the gut, the review states that homeostasis is restored, intestinal barrier integrity is reinforced, and short-chain fatty acids production is elevated. The authors acknowledge challenges surrounding clinical translation, standardization, and bioavailability as significant limitations. This review provides a theoretical framework for the application of natural polysaccharides as functional foods, nutraceuticals, or lead compounds in type 2 diabetes prevention and treatment.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Type 2 diabetes mellitus (T2DM) is a global metabolic pandemic affecting hundreds of millions of people, with current pharmacological therapies limited by adverse effects, long-term tolerability issues, and cost barriers. Natural polysaccharides—high-molecular-weight carbohydrate polymers derived from plants, fungi, marine organisms, and animal sources—have emerged as a promising class of multi-target bioactive agents for T2DM management. This comprehensive review first outlines the key pathophysiological mechanisms of T2DM, encompassing insulin resistance, pancreatic β-cell dysfunction, chronic inflammation, oxidative stress, and gut microbiota dysbiosis. We then systematically review the natural sources and structural classification of polysaccharides, alongside their extraction and purification methods. The core of this review examines the molecular mechanisms by which natural polysaccharides ameliorate T2DM: (1) enhancing insulin sensitivity and glucose metabolism via the PI3K/Akt and AMPK signaling pathways; (2) protecting pancreatic β-cells from apoptosis and promoting insulin secretion; (3) suppressing chronic inflammation through NF-κB and NLRP3 pathway inhibition; (4) attenuating oxidative stress via Nrf2/HO-1 pathway activation; and (5) restoring gut microbiota homeostasis, reinforcing intestinal barrier integrity, and elevating short-chain fatty acids production. Structure–activity relationship analyses indicate that hypoglycemic efficacy is tightly correlated with molecular weight, monosaccharide composition, glycosidic linkage types, degree of branching, three-dimensional conformation, and chemical derivatization. Finally, challenges surrounding clinical translation, standardization, and bioavailability are discussed, along with future research directions. This review provides a theoretical framework for the application of natural polysaccharides as functional foods, nutraceuticals, or lead compounds in T2DM prevention and treatment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.